Interestingly, HACE1 expression was also highly significantly underexpressed in all invasive ductal breast carcinoma compared with normal breast, suggesting that HACE1 loss is not confined to HER2 positivity (Figure 2b and Supplementary Figure 1). The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.